PUBLISHED FOR OPPOSITION
on 05 Nov 2024
Last Applicant/ Owned by
1-8, Doshomachi 3-chome, Chuo-ku
Osaka-shi, Osaka
JP
541-0045
Serial Number
90357057 filed on 03rd Dec 2020
Registration Number
N/A
Correspondent Address
Kumiko Ide
Filing Basis
1. intent to use
Disclaimer
NO DATA
LYBMESCA
Pharmaceutical preparations for the treatment of cerebrovascular disease, cerebral infarction, myocardial infarction, cardiomyopathy, ischemic heart disease, epidermolysis bullosa, intractable skin ulcers, spinal cord injury, amyotrophic lateral sclerosis, traumatic brain injury, ulcerative colitis, osteoarthritis, pulmonary fibrosis and atopic dermatitis
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cerebrovascular disease, cerebral infarction, myocardial infarction, cardiomyopathy, ischemic heart disease, epidermolysis bullosa, intractable skin ulcers, spinal cord injury, amyotrophic lateral sclerosis, traumatic brain injury, ulcerative colitis, osteoarthritis, pulmonary fibrosis and atopic dermatitis
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90357057
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TM20-0360
44D Filed
No
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 05th Nov 2024 | PUBLISHED FOR OPPOSITION |
| 16th Oct 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 12th Sep 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 11th Sep 2024 | CASE RETURNED TO EXAMINATION |
| 09th Sep 2024 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| 05th Sep 2024 | ASSIGNED TO PETITION STAFF |
| 26th Aug 2024 | NOTICE OF ALLOWANCE CANCELLED |
| 05th Aug 2024 | TEAS PETITION TO AMEND BASIS RECEIVED |
| 21st Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |